News from the Lung Institute

Press Contact: Maren Auxier     Email:     Phone: (813) 644-6127
New Data Suggests COPD Patients Will See Improvement from Stem Cell Therapy

New Data Suggests COPD Patients Will See Improvement from Stem Cell Therapy

The Lung Institute’s updated COPD patient outcomes data suggests that 84.5 percent of patients see an improvement in their quality of life.

Read More >

Other Press Articles

Lung Institute to Attend FDA Hearing on Stem Cell Regulation
Lung Institute Hosts New COPD Treatment Seminar in Knoxville, Offering Free Consultations

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.